Company

Statera Biopharma, Inc. (0001318641)

Standardized SEC financial data for Statera Biopharma, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001318641 · Pharmaceutical Preparations.

Gross margin

67.2%

Operating margin

-1000.0%

Net margin

-1000.0%

Return on equity

1000.0%

ROIC

-1000.0%

Free cash flow

-$28.4M

Debt / equity

-7.05×

Current ratio

0.37×

Ratios for fiscal year 2021, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Revenue	—	—	$1.1M	$1.1M	$0	$1.5M
Cost of revenue	—	—	—	—	$0	$488K
Gross profit	—	—	—	—

Balance sheet

USD	FY2017	FY2018	FY2019	FY2020	FY2021	FY2021
Cash & equivalents	$4.2M	$4.1M	$1.6M	$2.3M	—	$6.8M
Total current assets	$9.6M	$4.5M	$2.0M	$926K	—	$4.1M
Property, plant & equipment	$19K	$28K	$16K	$9K

Get 0001318641 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001318641/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001318641/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001318641 filings on SEC EDGAR →